Loading...
XTAI
1783
Market cap124mUSD
Dec 05, Last price  
43.30TWD
1D
0.58%
1Q
0.23%
Jan 2017
111.01%
IPO
110.09%
Name

Maxigen Biotech Inc

Chart & Performance

D1W1MN
XTAI:1783 chart
P/E
20.42
P/S
5.71
EPS
2.12
Div Yield, %
2.31%
Shrs. gr., 5y
0.42%
Rev. gr., 5y
8.52%
Revenues
681m
+9.41%
180,604,000172,440,000178,876,000221,997,000232,947,000245,686,000261,469,000336,388,000427,561,000427,680,000452,199,000457,691,000511,976,000604,431,000622,115,000680,651,000
Net income
190m
+14.68%
12,627,000-16,000,000-36,073,0002,764,0002,584,000-19,041,000-62,959,000-12,247,00015,787,00057,055,00060,111,00063,311,00087,667,000139,404,000165,828,000190,167,000
CFO
298m
+74.20%
19,271,000-16,764,000-76,640,00017,526,000-22,336,000-14,451,000-109,850,00034,718,00041,176,000170,581,00094,418,00074,394,000117,593,000268,338,000171,200,000298,223,000
Dividend
Jul 23, 20240.99873 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Maxigen Biotech Inc. engages in the development, manufacture, and marketing of biomedical and skincare products in Taiwan and internationally. The company offers Formagraft, a bone graft substitute; Formasetin, a bone void filler; and intra-articular injections under the ArtiAid, ArtiAid Plus, and ArtiBest names for use in orthopedic area. It also provides Foramic, a bone substitute granule; MaxiBone, a calcium phosphate ceramic; and GingivAid, a collagen dental grafts for use in orthopedic and dental areas. In addition, the company offers FormaAid, a collagen membrane; and E-TECH DENTISTAR II sterilizer and disinfectant for use in dental area, as well as HealiAid, a collagen wound dressing product for use in dental and wound dressing area. Further, it provides ophthalmic viscoelastic device under the ViscAid, PreviscAid, and BiVisc names; and Formaderm, a dermal filler injection for use in plastic surgery. Additionally, the company offers skincare products, including face, neck, body, limbs, and other masks; and make up remover, cleansing, exfoliating, toner, essence, men's care, sunscreen, body care, hand/foot care, and special care products. Maxigen Biotech Inc. was founded in 1998 and is based in Taoyuan City, Taiwan.
IPO date
May 18, 2011
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT